Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

2(50.0%)

Phase 2

1(25.0%)

Phase 1

1(25.0%)

4Total

N/A(2)

Phase 2(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials

NCT06737380Phase 1Recruiting

UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients

Role: collaborator

NCT06676410Phase 2Recruiting

Clinical Trial to Evaluate the Efficacy and Safety of Codivir® in Addition to Standard Antiretroviral Treatment for HIV Infection in Antiretroviral-naïve Participants

Role: collaborator

NCT03146273Not ApplicableCompleted

Study of Absorption Characteristics of Two Multivitamin Mineral Formulations (Gel vs. Tablet/Capsule)

Role: lead

NCT03058016Not ApplicableUnknown

Personalized Nutrition Prediction for Metabolic Syndrome Patients, an Open Single-center Study

Role: lead

All 4 trials loaded